A California biotechnology company said on Friday it was moving ahead with making a smallpox drug after getting a license from Gilead Sciences, Inc., which makes a similar drug. San Diego-based Chimerix said the agreement would allow it to sell its experimental drug CMX-001 to governments anywhere in the world. There is no treatment now for smallpox, which was eradicated but which the U.S. government says may someday be used in a biological weapon. The current smallpox vaccine can be used to prevent infection and even after a person has been exposed, but experts say it would be useful to have a drug on hand to treat anyone who may become infected anyway. Full Story
About OODA Analyst
OODA is comprised of a unique team of international experts capable of providing advanced intelligence and analysis, strategy and planning support, risk and threat management, training, decision support, crisis response, and security services to global corporations and governments.